K201726 · Haolang Medical USA Corporation · DQY · Jul 7, 2021 · Cardiovascular
Device Facts
Record ID
K201726
Device Name
Arterial Catheter
Applicant
Haolang Medical USA Corporation
Product Code
DQY · Cardiovascular
Decision Date
Jul 7, 2021
Decision
SESE
Submission Type
Traditional
Regulation
21 CFR 870.1250
Device Class
Class 2
Attributes
Therapeutic
Intended Use
The Arterial Catheter permits access to the peripheral arterial circulation.
Device Story
Arterial Catheter is a lumen peripherally inserted catheter assembly for short-term (less than 7 days) access to peripheral arterial circulation and pressure monitoring. Device components include introducer needle/catheter-over-needle, spring guide wire, and catheter assembly with extension tubing, slide clamp, and flex tube end cap. Insertion utilizes Seldinger catheter-over-guide-wire technique. Available in 18-24 ga sizes with lengths 2.5-23 cm. Catheters feature polyurethane hubs with Luer lock fittings. Device is provided sterile. Used by clinicians in clinical settings to facilitate arterial access; output is the established vascular access point for monitoring or fluid/medication delivery.
Clinical Evidence
No clinical data. Substantial equivalence supported by bench testing, including visual assessment, corrosion resistance, liquid/air leakage, flow rate, tensile testing (catheter/guidewire/needle), dimensional verification, simulated use/blood withdrawal, kink testing, torque strength, radiopacity, and needle penetration force. Biocompatibility, shelf-life validation, and sterilization (EO) validation were performed.
Technological Characteristics
Materials: SUS 304 (needle), Polyurethane (tubing/hub), ABS (needle hub), Niti/Stainless Steel (guide wire), PVC (flex tube), HDPE (guide wire slide), LDPE (protector). Standards: ISO 10555-1 (catheter performance), ISO 11070 (introducer/wire), ISO 10993-1 (biocompatibility), ISO 11607-1 (packaging), ISO 11135 (EO sterilization). Form factor: Catheter-over-guide-wire assembly with Luer lock. No software or electronic components.
Indications for Use
Indicated for patients requiring short-term access to the peripheral arterial circulation for pressure monitoring or other clinical needs.
Regulatory Classification
Identification
A percutaneous catheter is a device that is introduced into a vein or artery through the skin using a dilator and a sheath (introducer) or guide wire.
K210548 — Medline Integrated Arterial Catheter · Centurion Medical Products · May 17, 2022
K181563 — The ARTERIAL WAND Safety Introducer with Arterial Catheter made of ChronoFlex C with BioGUARD Technology · Access Scientific, LLC · Sep 26, 2018
K212370 — Leaderflex Mini and Leaderflex Nano · Vygon USA · Aug 29, 2022
Submission Summary (Full Text)
{0}------------------------------------------------
Image /page/0/Picture/0 description: The image shows the logos of the Department of Health & Human Services and the Food and Drug Administration (FDA). The Department of Health & Human Services logo is on the left, and the FDA logo is on the right. The FDA logo is a blue square with the letters "FDA" in white, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue.
July 7, 2021
Haolang Medical USA Corporation Lisa Xu RA Manager 1100 Bellevue Way NE 8A-533 Bellevue, Washington 98004
Re: K201726
Trade/Device Name: Arterial Catheter Regulation Number: 21 CFR 870.1250 Regulation Name: Percutaneous Catheter Regulatory Class: Class II Product Code: DQY Dated: September 1, 2020 Received: September 18, 2020
### Dear Lisa Xu:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part
{1}------------------------------------------------
801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4. Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device (https://www.fda.gov/medical-devices/ device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-andcontinuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatory-assistance/contact-usdivision-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
for Lydia Glaw Assistant Director DHT2C: Division of Coronary and Peripheral Intervention Devices OHT2: Office of Cardiovascular Devices Office of Product Evaluation and Ouality Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
## Indications for Use
510(k) Number (if known) K201726
Device Name Arterial Catheter
Indications for Use (Describe)
The Arterial Catheter permits access to the peripheral arterial circulation.
Type of Use (Select one or both, as applicable)
> Prescription Use (Part 21 CFR 801 Subpart D)
| Over-The-Counter Use (21 CFR 801 Subpart C)
#### CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
#### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
{3}------------------------------------------------
# 510(K) Summary
Prepared in accordance with the requirements of 21 CFR Part 807.92
## Prepared Date: June 1, 2021
## 1. Submitter's Information
The submitter of this pre-market notification is:
| Name: | Haolang Medical USA Corporation |
|-----------------|-----------------------------------------------------|
| Address: | 1100 Bellevue Way NE 8A-533, Bellevue, WA 98004 USA |
| Contact person: | Lisa Xu |
| Title: | RA Manager |
| E-mail: | lisa.xu@haolangmed.com |
| Tel: | 1-425-503-6325 |
## 2. Device Identification
| Trade/Device Name: | Arterial Catheter |
|--------------------|--------------------------------|
| Models: | 18Ga, 20Ga, 21Ga, 22Ga, 24Ga |
| Regulation Number: | 21 CFR 870.1250 |
| Common Name: | Percutaneous Arterial Catheter |
| Regulation Class: | Class II |
| Product Code: | DQY |
## 3. Predicate Device
| 510(K) number: | K171146 |
|--------------------|-------------------------------------------------|
| Device Name: | Arrow Seldinger Arterial Catheterization Device |
| Manufacturer: | Arrow International, Inc. |
| Regulation Number: | 21 CFR 870.1250 |
| Regulation Name: | Percutaneous Catheter |
| Regulation Class: | Class II |
| Product Code: | DQY |
## 4. Device Description
The Arterial Catheter is a lumen peripherally inserted catheter assembly designed to perform short term access to the peripheral arterial circulatory system for less than 7 days, it is also intended to be used for pressure monitoring. It consists of an introducer needle or catheter-over-needle assembly, spring guide wire, and a catheter assembly that incorporates an extension tubing segment with a slide clamp and a flex tube end cap. These components are used together for catheter insertion using the "Seldinger" catheter-over-guide-wire insertion technique, which divided into three types according to structure: Standard Seedinger; Modified Seedinger-Integrated; Modified Seedinger-Sleeve.
The Arterial Catheter is available in 18 ga, 20 ga, 21 ga, 22 ga and 24 ga, the corresponding diameter of guide wire is 0.025", 0.018", 0.015", 0.012". Configurations with usable lengths of
Haolang Medical USA Corporation
{4}------------------------------------------------
2.5 cm to 23 cm. The catheters are attached to an injection molded polyurethane hub with Luer lock fittings for access attachment.
The Arterial Catheter is provided sterile.
### 5. Indication for use
The Arterial Catheter permits access to the peripheral arterial circulation.
### 6. Comparison to Predicate Device
Compared to the predicate devices, the subject device has same intended use, similar product design, performance effectiveness as the predicate device as summarized in the following table.
| Feature | Subject device | Predicate device | Comments |
|------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Manufacturer/<br>K# | Haolang Medical USA<br>Corporation | Arrow International, Inc.<br>K171146 | -- |
| Trade name<br>and model | Arterial Catheter | Arrow Seldinger Arterial<br>Catheterization Device | -- |
| Classifications<br>name and<br>Regulation<br>Name | 21 CFR 870.1250<br>Percutaneous Catheter<br>Class II<br>DQY | 21 CFR 870.1250<br>Percutaneous Catheter<br>Class II<br>DQY | Same |
| Indications for<br>use | The Arterial Catheter<br>permits access to the<br>peripheral arterial<br>circulation. | The Arrow Seldinger<br>Arterial Catheterization<br>Devices permit access to<br>the peripheral arterial<br>circulation or to other<br>small vessels | Same |
| Catheter<br>Gauge Sizes | 18 ga, 20 ga, 21 ga, 22 ga<br>and 24 ga | 18 ga, 20 ga, 22 ga and 24<br>ga | We have one more<br>size than predicate<br>device, but we have<br>performed the<br>performance test,<br>the difference does<br>not raise the new<br>risk. |
| Catheter<br>Usable Length | 2.5 cm to 23 cm | 5cm - 23cm | According to<br>different usage<br>requirements, our<br>catheter length<br>range is larger, but<br>we have also<br>performed the<br>performance test on<br>which is smaller<br>than the range of<br>predicate device, the<br>difference does not<br>raise the new risk. |
| Introducer<br>needle size | 18Ga, 20Ga, 21Ga,<br>22Ga,23Ga, 24Ga, 26Ga | 18 ga.: 18 ga X 5cm-<br>7cm (2"-2 $\frac{3}{4}$ ")<br>20 ga : 20 ga X 4cm- | Different, The<br>coverage of the<br>Introducer needle |
| 7cm (1 ½"- 2 ¾")<br>22 ga.: 22 ga. X 4cm (1<br>1 ½") | size is more than<br>that of the predicate<br>device. We used a<br>thinner needle and<br>undergoing the<br>performance test<br>according to the ISO<br>10555-1 and ISO<br>11070. The<br>difference does not<br>affect the safety and<br>performance of the<br>device. | | |
| Spring Wire<br>Guide Size | 0.012", 0.015", 0.015",<br>0.018", 0.021", 0.025" | 18 ga.: 0.64mm diameter X<br>33.5cm-60cm (13"-23")<br>20 ga.: 0.533mm diameter X<br>35cm-50cm (13 ¾"-20")<br>22 ga.: 0.533mm<br>diameter X 35cm (13 ¾")<br>24 ga.: 0.46mm diameter<br>X 25cm (9 ¾") | Different, The size<br>coverage of spring<br>Wire Guide Size is<br>more than that of the<br>predicate device.<br>We are undergoing the<br>performance test<br>according to the ISO<br>10555-1 and ISO<br>11070. The<br>difference does not<br>affect the safety and<br>performance of the<br>device. |
| Spring Wire<br>Guide Tip | Straight | Straight and J-tip | Same |
| Spring Wire<br>Guide Depth<br>Markings | Yes | Yes, etched on straight<br>spring wire guides. Not on J-<br>tip spring wire guides | Same |
| Introducer<br>Method | Introducer needle and<br>introducer catheter-over-<br>needle | Introducer needle and<br>introducer catheter-over-<br>needle | Same |
| Sterilization<br>Method | EO | EO | Same |
| Shelf life | 3 years | 2 years | Different, we have<br>conducted the shelf<br>life validation based<br>on the 3 years, the<br>performance is<br>acceptable, the<br>difference does not<br>affect the safety and<br>performance of the<br>device. |
| Packaging | PET/LDPE film mated<br>with Tyvek | PET/LDPE film mated<br>with Tyvek | Same |
| | | | |
| Material | 1. Introducer Needle: SUS 304<br>2. Tubing, Catheter Hub<br>and Luer: PU<br>3. Needle Hub: ABS<br>4. Spring guide wire: Niti&<br>Stainless Steel<br>5. Flex tube: PVC<br>6. Guide wire slide: HDPE<br>7. Catheter protector tube:<br>LDPE | 1. Introducer Needle: SUS 304<br>2. Tubing, Catheter Hub and<br>Luer: Polyether urethane<br>3. Needle Hub: ABS<br>4. Spring guide wire: SUS 304<br>5. Flex tube: Not specified<br>6. Guide wire slide: Not<br>specified<br>7. Catheter protector tube:<br>Not specified | Different, The<br>introducer needle<br>and the catheter<br>body are made of<br>the same material,<br>but the production<br>process and<br>chemical<br>characterization<br>information of the<br>material is unknown,<br>so it is impossible to<br>prove that its<br>biocompatibility is<br>equivalent. We<br>conducted the<br>biocompatibility<br>evaluation on<br>subject device and<br>determined the<br>endpoint according<br>to ISO 10993-1,<br>which prove that the<br>material of subject<br>device is<br>biocompatibility, the<br>difference of<br>material does not<br>affect the safety and<br>performance of the<br>device. |
{5}------------------------------------------------
### Traditional 510(k) Submission of Arterial Catheter
{6}------------------------------------------------
## 7. Performance Data
#### Clinical test:
Clinical testing is not required.
#### Non-clinical data
Arterial Catheter comply with:
#### Performance:
According to the requirements of FDA guidance<Peripheral Percutaneous Transluminal Angioplasty (PTA) and Specialty Catheters - Premarket Notification (510(k)) Submissions> ISO 10555-1:2013 we performed the following testing:
- Visual assessment -
- -Corrosion Resistance
- Liquid Leakage Testing -
- Air Leakage Testing -
- Flow Rate Testing Report -
- Catheter Tensile Testing -
- Guidewire Tensile Testing -
Haolang Medical USA Corporation
{7}------------------------------------------------
- Dimensional verification -
- Simulated use and Simulated Blood Withdrawal -
- -Kink Testing
- -Torque Strength Testing
- Radiopacity Testing -
- Needle testing: Visual assessment; Tensile strength testing of needle and hub; Penetration force
#### Shelf Life:
Accelerated aging tests were conducted to confirm the validity of the 3 years shelf life.
#### Biocompatibility:
The compatibility of the skin-contact component material in the finished product meets the requirement of Biocompatibility. The Biological Evaluation Tests are in compliance with the standards of ISO 10993-1, "Biological Evaluation of Medical Devices".
#### Sterilization:
- -ISO 11607-1:2016 Packaging for terminally sterilized medical devices - Part 1: Requirements for materials, sterile barrier systems and packaging systems.
- -ISO 11135: 2014 Sterilization of health care products -- Ethylene oxide -- Requirements for the development, validation and routine control of a sterilization process for medical devices
#### 9. Conclusion
Based on the results of above testing, the Arterial Catheter is substantially equivalent to the predicate device Arrow Seldinger Arterial Catheterization Device (K171146).
Panel 1
/
Sort by
Ready
Predicate graph will load when search results are available.
Embedding visualization will load when search results are available.
PDF viewer will load when search results are available.
Loading panels...
Select an item from Submissions
Click any panel, subpart, regulation, product code, or device to see details here.
Section Matches
Results will appear here.
Product Code Matches
Results will appear here.
Special Control Matches
Results will appear here.
Loading collections...
Loading
My Alerts
You will receive email notifications based on the filters and frequency you set for each alert.